Weiss Multi-Strategy Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,873	Closed	-$546K	–	810
2021 Q4	$546K	Buy	+4,873	New	+$588K	0.01%	540
2014 Q2	–	Sell	-218,910	Closed	-$9.87M	–	953
2014 Q1	$10.4M	Buy	+218,910	New	+$11.2M	0.21%	126

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's XBI Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 4,873 shares — an estimated $546K sold.

Weiss Multi-Strategy Advisers first reported a position in XBI in Q1 2014 and held it in 2 quarters. The position peaked at $10.4M in Q1 2014. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 4,873 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $546K.
Weiss Multi-Strategy Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's State Street SPDR S&P Biotech ETF position peaked at $10.4M in Q1 2014.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.